AH
Publicaties op Oncologisch.com
Distant disease-free survival as a surrogate endpoint for totale overleving in randomised trials of neoadjuvant thera...
Neoadjuvant Paclitaxel/Olaparib in Comparison to Paclitaxel/Carboplatin in Patients with HER2-Negative Breast Cancer ...
Ribociclib-werkzaamheid en prognose bij mammacarcinoom: analyse
Endocriene therapie plus trastuzumab-pertuzumab versus gede-escaleerde chemo bij mammacarcinoom: PHERGain OS
Circulerende tumorcellen bij neoadjuvant behandeld mammacarcinoom: meta-analyse